NEW YORK, Sept. 5, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, has issued a reminder to sellers of Sinovac Biotech Ltd shares. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the “Collection Period”), to which October 17, 2022 Deadline for Lead Plaintiff in the lawsuit against 1Globe Capital LLC and certain of its officers.

SO WHAT: If you sold Sinovac Securities during the Class Period, you may be entitled to compensation without paying out-of-pocket expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To participate in the Sinovac Class Action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by October 17, 2022 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these law firms do not actually conduct securities class actions, but are merely intermediaries who refer clients or work with law firms who actually hear the cases. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has hundreds of…